182 related articles for article (PubMed ID: 12140288)
21. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
[TBL] [Abstract][Full Text] [Related]
23. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
[TBL] [Abstract][Full Text] [Related]
24. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
[TBL] [Abstract][Full Text] [Related]
25. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
[TBL] [Abstract][Full Text] [Related]
26. Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.
Yam CH; Ng RW; Siu WY; Lau AW; Poon RY
Mol Cell Biol; 1999 Jan; 19(1):635-45. PubMed ID: 9858587
[TBL] [Abstract][Full Text] [Related]
27. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
Salamina M; Montefiore BC; Liu M; Wood DJ; Heath R; Ault JR; Wang LZ; Korolchuk S; Baslé A; Pastok MW; Reeks J; Tatum NJ; Sobott F; Arold ST; Pagano M; Noble MEM; Endicott JA
J Mol Biol; 2021 Mar; 433(5):166795. PubMed ID: 33422522
[TBL] [Abstract][Full Text] [Related]
28. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
Westbrook L; Manuvakhova M; Kern FG; Estes NR; Ramanathan HN; Thottassery JV
Cancer Res; 2007 Dec; 67(23):11393-401. PubMed ID: 18056467
[TBL] [Abstract][Full Text] [Related]
29. High expression of Cks1 in human non-small cell lung carcinomas.
Inui N; Kitagawa K; Miwa S; Hattori T; Chida K; Nakamura H; Kitagawa M
Biochem Biophys Res Commun; 2003 Apr; 303(3):978-84. PubMed ID: 12670508
[TBL] [Abstract][Full Text] [Related]
30. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
Spruck C; Strohmaier H; Watson M; Smith AP; Ryan A; Krek TW; Reed SI
Mol Cell; 2001 Mar; 7(3):639-50. PubMed ID: 11463388
[TBL] [Abstract][Full Text] [Related]
31. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
33. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure and mutational analysis of the Saccharomyces cerevisiae cell cycle regulatory protein Cks1: implications for domain swapping, anion binding and protein interactions.
Bourne Y; Watson MH; Arvai AS; Bernstein SL; Reed SI; Tainer JA
Structure; 2000 Aug; 8(8):841-50. PubMed ID: 10997903
[TBL] [Abstract][Full Text] [Related]
35. High-throughput screening for inhibitors of the Cks1-Skp2 interaction.
Huang KS; Vassilev LT
Methods Enzymol; 2005; 399():717-28. PubMed ID: 16338391
[TBL] [Abstract][Full Text] [Related]
36. The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment.
Frontini M; Kukalev A; Leo E; Ng YM; Cervantes M; Cheng CW; Holic R; Dormann D; Tse E; Pommier Y; Yu V
Dev Cell; 2012 Aug; 23(2):356-70. PubMed ID: 22898779
[TBL] [Abstract][Full Text] [Related]
37. Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression.
Hoellein A; Graf S; Bassermann F; Schoeffmann S; Platz U; Hölzlwimmer G; Kröger M; Peschel C; Oostendorp R; Quintanilla-Fend L; Keller U
Mol Cell Biol; 2012 Jul; 32(13):2416-27. PubMed ID: 22508990
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy.
Suzuki S; Fukasawa H; Misaki T; Togawa A; Ohashi N; Kitagawa K; Kotake Y; Niida H; Hishida A; Yamamoto T; Kitagawa M
Genes Cells; 2011 Nov; 16(11):1110-20. PubMed ID: 22017545
[TBL] [Abstract][Full Text] [Related]
39. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
